Polar Asset Management Partners’s Envoy Medical COCH Stock Holding History

Polar Asset Management Partners’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-80,000	Closed	-$189K	–	744
2024 Q2	$189K	Hold	80,000	–	–	﹤0.01%	455
2024 Q1	$308K	Sell	80,000 -50,000	-38%	-$146K	0.01%	479
2023 Q4	$219K	Sell	130,000 -70,000	-35%	-$137K	﹤0.01%	487
2023 Q3	$2.09M	Sell	200,000 -200,000	-50%	-$2M	0.05%	389
2023 Q2	$4.1M	Hold	400,000	–	–	0.07%	341
2023 Q1	$4.02M	Sell	400,000 -1,092,549	-73%	-$10.9M	0.06%	392
2022 Q4	$15M	Hold	1,492,549	–	–	0.18%	138
2022 Q3	$14.7M	Hold	1,492,549	–	–	0.18%	160
2022 Q2	$14.6M	Hold	1,492,549	–	–	0.17%	165
2022 Q1	$14.6M	Hold	1,492,549	–	–	0.16%	159
2021 Q4	$14.5M	Sell	1,492,549 -7,451	-0.5%	-$72.7K	0.15%	152
2021 Q3	$14.6M	Hold	1,500,000	–	–	0.14%	176
2021 Q2	$14.6M	Buy	+1,500,000	New	+$14.6M	0.15%	152

Other funds holding COCH

AMC

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAG

HighPoint Advisor Group Downers Grove, Illinois $2.84B AUM 31.94% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Polar Asset Management Partners's COCH Position: Q3 2024 in Review

Polar Asset Management Partners sold out of Envoy Medical (COCH) in Q3 2024, closing a stake of 80,000 shares — an estimated $189K sold.

Polar Asset Management Partners first reported a position in COCH in Q2 2021 and held it in 13 quarters. The position peaked at $15M in Q4 2022. 18 funds tracked by Wall St. Rank hold COCH as of Q3 2024.

Polar Asset Management Partners reported no remaining Envoy Medical position as of Q3 2024 after selling out during the quarter.
Polar Asset Management Partners sold 80,000 Envoy Medical shares in Q3 2024, an estimated $189K.
Polar Asset Management Partners first reported a position in Envoy Medical in Q2 2021 and held it in 13 quarters.
Polar Asset Management Partners's Envoy Medical position peaked at $15M in Q4 2022.
18 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.